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Abstract
To complete its life cycle, protozoan parasites of the genus Leishmania undergo at least three major developmental transitions. However,
previous efforts to identify genes showing stage regulated changes in transcript abundance have yielded relatively few. Here we used
expression proﬁling to assess changes in transcript abundance in three stages: replicating promastigotes and infective non-replicating
metacyclics, which occur in the sand ﬂy vector, and in the amastigote stage residing with macrophage phagolysosomes in mammals.
Microarrays were developed containing 11,484 PCR products that included a number of known genes and 10,464 random 1kb genomic
DNA fragments. Arrays were hybridized in triplicate and genes showing two-fold or greater changes in 2/3 experiments were scored as
differentially expressed. Remarkably, only about one percent of the DNAs expression varied by this criteria, in either stage comparison.
Northern blot analysis conﬁrmed the predicted change in mRNA abundance for most of these (68%). This set of genes included most of
those previously identiﬁed in the literature as differentially regulated as well as a number of novel genes. Notably, Leishmania maxicircle
transcripts showed strong up-regulation in metacyclic and amastigote parasites, probably associated with changes in parasite energy
metabolism. However, current data suggest that expression proﬁling using shotgun DNA libraries signiﬁcantly underestimates the extent
of regulated transcripts.
© 2004 Elsevier B.V. All rights reserved.
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1. Introduction
Trypanosomatid protozoan parasites of the genus
Leishmania are the causative agents of leishmaniasis, a
widespread group of parasitic diseases varying from spon-
taneously healing skin lesions to fatal visceral disease. Two
million new cases are diagnosed each year with more than
397 million people at risk [1], and in endemic regions
leishmaniasis is a common opportunistic AIDS infection
[2]. The discovery of visceral leishmaniasis in foxhounds in
upper New York State, and the incidence of leishmaniasis
in soldiers operating in endemic countries underscore the
potential for spread [3,4]. Current hope for new chemother-
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apeutic or vaccination therapies lies in research programs
oriented towards identifying key processes essential for
parasite growth, survival in the mammalian host, or trans-
mission by its insect vector.
Leishmania are transmitted by phlebotomine sand ﬂies to
humans and many animal reservoirs. In the sand ﬂy midgut,
Leishmania replicate as ﬂagellated procyclic promastigotes,
which are noninfective. As procyclics enter stationary phase
they differentiate to the infective metacyclic stage, which is
adapted for transmission to the mammalian host [5]. Once
deposited into the host, metacyclics are phagocytosed by
macrophages, where they transform into the non-motile, in-
tracellular, replicative amastigote, which are adapted to sur-
vive within the hostile environment of the phagolysosome.
Understanding how Leishmania carry out these develop-
mental transitions and the mechanisms that they employ to
survive within each host is critical to the development of
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effective treatment and cure of these pathogens. The identi-
ﬁcation of genes whose products show strong stage-speciﬁc
expression is a well-established paradigm in microbial
pathogenesis for the identiﬁcation of important pathways
essential for parasite survival, and one of the goals of the
work described here.
Leishmania exhibits an unusual combination of mecha-
nisms of gene expression. Trypanosomatid protozoans use a
polycistronic transcriptional approach, in which pre-mRNAs
synthesized across hundreds of kb yield monocistronic mR-
NAs, following processing reactions including a coupling
of trans-splicing and polyadenylation [6]. Thus, the de-
pendency on promoter-based transcription initiation mech-
anisms for the control of mRNA level is greatly reduced;
perhaps as a result, greater emphasis may be placed on
post-transcriptional regulatory mechanisms such as mRNA
stability and translation, and protein turnover [7]. Thus far,
efforts to identify genes showing stage-dependent variation
intranscriptabundance,usingmethodssuchassubtractiveor
differential hybridization, or RDA, have yielded only a mod-
est number of regulated genes [8–12]. Nonetheless, many of
the genes thus identiﬁed have been implicated in key aspects
of the parasite infectious cycle.
Many workers have focused on Leishmania major, one
of the species associated with cutaneous leishmaniasis for
which excellent animal models of disease susceptibility and
resistance exist [13]. The ∼34Mb genome of L. major is
distributed amongst 36 chromosomes and is estimated to en-
code about 8000 genes [14]. With the eventual availability of
the parasite genome and emergence of the ﬁeld of genome
science, new opportunities to probe Leishmania gene ex-
pression have arisen. Expression proﬁling through the use
of DNA microarrays offers a powerful approach for mea-
suring changes in transcript abundance, as many thousands
of genes are studied simultaneously [15,16]. Typically spe-
ciﬁc probes consisting of either oligonucleotides or DNAs
are deposited on solid supports, and hybridization to cDNAs
assessed by the aid of ﬂuorophores, which can be either di-
rectly or indirectly incorporated into the cDNA.
At the time we initiated these studies a small fraction
of the Leishmania major genome had been sequenced, and
we developed a ∼1-kb random shotgun genomic DNA se-
quence library and characterized a collection of ∼10,000
of these for use in microarray creation [17]. Similar ap-
proaches have been taken with Plasmodium falciparum and
Trypanosoma brucei [18,19]. This tactic seemed well suited
for Leishmania, as the transcript/gene density is high, in-
trons are exceedingly rare, and the average transcript size
is 3.6kb [17,20,21]. Characterization of this shotgun library
set suggested that it was potentially able to identify about
2/3 of all Leishmania transcripts [17], making it a useful re-
source for genome-wide approaches. In this work we have
used this DNA collection and expression proﬁling method-
ology to focus on the three key parasite stages: replicating
promastigotes, infectious metacyclics and amastigotes de-
rived from lesions in mice.
2. Materials and methods
2.1. Parasite culture
Fully virulent L. major Friedlin clone V1 (MHOM/JL/
80/Friedlin) were grown as promastigotes at 26 ◦C in one
liter bottles containing 500ml of M199 medium [22] on a
rotating platform to increase aeration. Logarithmic growth
phase promastigotes were harvested at a density of 2 ×
106/ml and were grown in media at pH 7.4. Metacyclic
parasites were grown in the same media at pH 5.5 with
HEPES replaced 4-morpholinoethanesulfonic acid (MES),
and prepared by negative selection with peanut agglutinin
(PNA-metacyclics; [5]). Amastigotes were recovered from
BALB/cJ mice one month following infection with 5×107
stationary phase parasites in the footpad; at this time, the av-
erage lesion size was 2–4mm without visible necrosis [23].
2.2. Nucleic acid isolation and northern blotting
Genomic DNA was isolated from late logarithmic phase
promastigotes by the LiCl method [24]. RNA was isolated
using the Trizol method (Invitrogen, CA), subsequently
treated with DNAse and puriﬁed using QIAGEN RNAeasy
columns (QIAGEN, Germany). DNA and RNA were quanti-
ﬁed by spectrophotometry; RNA was analyzed by Northern
blotting as described [25]. The same RNA preparations were
used in both microarray and Northern blot experiments.
Radiolabeled probes were prepared with the Prime-It II
Random Primer Labeling Kit (Stratagene, CA). Hybridiza-
tion was quantiﬁed using a Storm PhosphorImager and
IMAGEQUANT software (Amersham Biosciences, CA).
2.3. Shotgun sequence analysis
Sequences from shotgun clones not previously reported
were obtained from double-stranded plasmid DNA tem-
platesusingdyeterminatorsandAmpliTaqDNApolymerase
and submitted to the GenBank (NCBI) genome survey
sequence (GSS) database (http://www.ncbi.nlm.nih.gov).
GenBank accession numbers were CC144545-CC111546
and CC14449-CC144558.
2.4. Microarray preparation
PCR ampliﬁed DNAs were generated by using appro-
priate primers, either gene-speciﬁc or the universal M13
forward and M13 reverse primers for the 1kb random shot-
gun library; detailed information on the speciﬁc DNAs and
primers can be obtained from the authors on request. PCR
products were puriﬁed by ethanol precipitation, washed
with 75% ethanol, re-suspended in water, quantiﬁed using
PicoGreen dye (Molecular Probes, OR) and checked by
standard agarose gel electrophoresis. The average DNA con-
centration was 450ngl−1. DNAs were spotted in 0.005%
Nonidet P-40 (Sigma, MO) onto poly-l-lysine coated slidesN.S. Akopyants et al./Molecular & Biochemical Parasitology 136 (2004) 71–86 73
using an Affymetrix 417 arrayer (Affymetrix, CA). cDNA
was synthesized from 25g of total RNA by direct incor-
poration of Cy3 or Cy5 ﬂuorophore-labeled dCTP during
ﬁrst-strand synthesis using an oligo (dT) primer (Invitrogen,
CA). Three different labeling reactions were done from a
single RNA preparation from each stage to facilitate the
assessment of technical variability. Hybridizations were per-
formed as described [26] with the following modiﬁcations:
cDNA was dissolved in 40l microarray buffer (Sigma,
MO) and hybridization was performed in a water bath at
45 ◦C for 16h. The arrays were washed at room temperature
in 150mM NaCl, 15mM sodium citrate pH 7.5 (1 × SSC)
for 5min and then rinsed twice in 0.2 × SSC for 2min.
Each hybridization experiment was performed in triplicate.
2.5. Data processing and analysis
Hybridization of Cy3- and Cy5-labelled cDNA was
quantiﬁed using an Affymetrix 428 ﬂuorescent scanner
(Affymetrix, CA). From the primary scanned images data
were extracted and analyzed using appropriate software
(IMAGENE 4.2; BioDiscovery, CA). Depending on the
scanner photomultiplier (PMT) setting, the intensity of some
spots would fall outside of the linear range of the scanner.
Thus each slide was scanned at several PMT settings in
order to increase the sensitivity and extend the linear range,
and an algorithm was developed to combine these data into
a single value.
The data were normalized by setting the median of the
log2 transformed Cy3/Cy5 ratios to zero, for those spots
showing intensities at least two-fold over local background,
calculated from an annulus around the spot, in both chan-
nels. Certain spots that failed this criterion in a single chan-
nel were restored to the pool of the candidates after nor-
malization. The complete dataset can be obtained from the
authors on request.
3. Results
3.1. Leishmania major microarray creation and RNA
recovery across the infectious cycle
DNA microarrays comprising a total of 11,484 DNA
elements were created, using PCR-ampliﬁed DNAs aris-
ing from 10,464 random 1kb ‘shotgun’ genomic DNA
fragments, 95 ORFs from chromosomes 1 and 3 [21,27],
multiple replicas of genes known to be differentially regu-
lated from the literature and our laboratory, and 100 control
DNAs (cloning vectors or derived from other species such
as mouse, yeast and Escherichia coli). This array of 11,484
elements was used to study differential gene expression
for the three major stages of the Leishmania infectious cy-
cle: (1) non-infective replicating procyclic promastigotes,
(2) infective, stationary phase metacyclic promastigotes,
and (3) amastigotes recovered from a progressing lesion
in BALB/c mice (here the growth phase is undeﬁned and
probably heterogeneous).
3.2. Expression proﬁling of three major Leishmania
developmental stages
First, control experiments comparing Cy3- versus
Cy5-labeled log phase procyclic promastigote RNA were
performed to assess concerns about preferential label in-
corporation into particular sequences. These data showed
that about 0.5% of the spots exhibited two-fold or greater
differences in intensity from each other. This ‘dye effect’
has been seen by others [28] and its basis is not well under-
stood; unless otherwise indicated, we have eliminated these
DNAs from the analysis below.
The results from a representative hybridization experi-
ment comparing Cy5-labeled logarithmic phase procyclic
RNA versus Cy3-labeled stationary phase metacyclic RNA
are summarized in Fig. 1. In this plot we restricted the analy-
sis to the 10,464 random DNA fragments in order to provide
an unbiased view of the Leishmania major genome. A plot
of the intensities showed that most spots ﬁt a predominantly
linear relationship, and that 86% of the spots yielded sig-
niﬁcant hybridization intensities (two-fold over local back-
ground; Fig. 1A). The data in Fig. 1A was ﬁrst transformed
to the log2 ratio of the Cy5/Cy3 intensities, and then nor-
malized (Fig. 1B; Section 2). Remarkably, most Leishma-
nia spots yielded expression ratios of nearly 1 (log2 = 0),
with only 333 (3.2%) or fewer DNAs in a single experiment
showing regulation of greater than two-fold between stages
(Fig. 1B). Similar results were obtained in every experi-
ment performed comparing metacyclic or amastigote RNA
expression (not shown). In contrast, a similar analysis in the
yeast Saccharomyces cerevisiae showed that just the transi-
tion from replicating to stationary phase was associated with
two-fold or greater changes in expression of 27% of ORF
mRNAs (Fig. 1B; [29]).
The data in Fig. 1 and other analyses suggested that ex-
pression ratios of less than two-fold potentially could be
considered statistically signiﬁcant. For example, by chang-
ing the cut-off to 1.75-fold, the number of spots increased
0.7–1% for any single replicate. However, in keeping with
the work of others, the modest number of replicates, and the
discussion below, we have focused our discussion to tran-
scripts showing at least two-fold differential expression in
the following analysis.
We displayed the results from our studies in the form of
Venn diagrams showing the number of DNAs identifying
transcripts exhibiting at least two-fold change in one, two
or all three experiments for a given developmental transi-
tion. In metacyclic versus procyclic promastigotes compar-
isons (Fig. 2B, Table 1), a total of 333 (3.2%) of the spots
showed transcript abundance changes in 1 or more experi-
ments, with 48 (0.5%) in 3/3 experiments and 84 (0.8%) in
2/3 experiments; similar results were obtained with compar-
isons of amastigotes versus procyclic promastigotes (320,74 N.S. Akopyants et al./Molecular & Biochemical Parasitology 136 (2004) 71–86
Fig. 1. Expression proﬁling of procyclic vs. metacyclic transcripts in L. major. Panel A: Results of a single representative experiment comparing
logarithmic growth phase promastigotes (Cy5, Y-axis) vs. PNA- metacyclic parasites (Cy3, X-axis). Intensities are shown prior to ‘normalization’ of Cy3
vs. Cy5 intensities but after adjustment of PMT intensities to account for saturation. The solid line indicates the median after normalization. Dashed lines
indicate ±2-fold difference. Panel B: Distribution of log2 transformed normalized ratios for a single microarray experiment (metacyclic promastigotes
versus logarithmic promastigotes; solid black line). A similar analysis of a published data set for logarithmic vs. stationary phase S. cerevisiae (dotted
line) is shown [29]. Using two-fold or greater changes in relative expression as a criteria, 3.2% of the L. major genes varied in this experiment; analogous
comparisons yield values of 18–27% in S. cerevisiae underoing growth phase transitions or differentiation [29,57].
Fig. 2. Venn diagram comparison of microarray datasets for amastigote or metacyclic vs. procyclic promastigote experiments. The results of three different
experiments for each comparison are shown in each panel; this analysis includes only the 10,464 random shotgun fragment probes in order to provide
an unbiased view of the Leishmania genome. The larger number is the total number of spots showing a two-fold or greater change in abundance; “+”
or “−”, respectively means elevated or decreased relative to logarithmic growth phase procyclic promastigotes: (A) lesion amastigotes; (B) infectious
metacyclic promastigotes.
Table 1
Genes showing two-fold or greater changes in transcript abundance by shotgun DNA microarray expression proﬁling in Leishmania major
Experiment ≥1 experiment ≥2 experiments 3 experiments
Lesion amastigotes/logarithmic promastigotes 3.1% (320) 0.9% (96) 0.6% (64)
PNA-metacyclic promastigotes/logarithmic promastigotes 3.2% (333) 0.8% (84) 0.5% (48)
The number in parenthesis refers to the total number of genes identiﬁed by each criterion. These data are summarized from Fig. 2 where the breakdown
in ‘up’ or ‘down’ regulated transcripts abundance is also presented.N.S. Akopyants et al./Molecular & Biochemical Parasitology 136 (2004) 71–86 75
64 and 96, respectively; Fig. 2A). Such variation is common
in microarray analysis and the results shown in Fig. 2 com-
pare well with similar consistency tests reported by others
with different species [30,31].
3.3. Northern blot analysis of DNAs showing differential
expression in microarrays
Encouragingly, a survey of the genes scored in the Venn
analysis above as ‘regulated’ in 2/3 experiments or better
revealed many that were expected based upon prior studies,
including HASP, SHERP, -tubulin and histones (discussed
below). However, relative transcript levels have been deter-
mined for a limited number of L. major genes, typically by
only a single lab and often for a single developmental tran-
sition. Thus we performed Northern blot analysis of pro-
cyclic promastigote, metacyclic and amastigote RNAs (the
same preparations used in the microarray analysis) for 107
of the shotgun L. major fragments. We focused primarily
on those genes showing regulation in 2/3 microarray experi-
ments, with a secondary emphasis on those showing regula-
tion in just one or no experiment. Ribosomal RNA staining
was used as a control to ensure equal loading amongst sam-
ples (Fig. 3F). For most genes (61.7%), one or two mRNA
Fig. 3. Northern blot analysis. Panels A–E and G–L: Northern blots were performed with total RNA isolated from logarithmically growing promastigotes
(P), metacyclic promastigotes (M), and lesion amastigotes (A), using the indicated hybridization probes. Probe numbers correspond to the genome survey
sequence clones reported by Akopyants et al. [17] and the annotations arose from searches of the Leishmania major genome project. Only the relevant
portion of each blot is shown. The microarray expression ratios (fold-change) of M or A relative to P expression are shown underneath each Northern
blot. MW, molecular weight marker. Panel F: A representative ethidium bromide stained gel showing the loading controls of the ribosomal RNAs.
bands were observed and quantitated; for others (16.7%) a
‘smear’ was obtained, perhaps indicative of transcripts aris-
ing from a multi- or repetitive gene family. Particularly in-
triguing “smears” arose with probes containing the LTAS
telomeric-associated sequences (Fig. 3L). For some genes
(21.5%) we did not obtain a Northern blot signal; these were
excluded from the statistical analysis below, as the negative
result could reﬂect technical problems and they were not
repeated. These data are summarized in Table 2 and repre-
sentative Northern blots are shown in Fig. 3, including the
quantitation derived from the average of the three microar-
ray comparisons for each set of experiments. Examples are
shown where the Northern blot and microarray results were
in good agreement, as well as ones where discrepancies were
found.
First, we considered those comparisons in which expres-
sion proﬁling had predicted at least a two-fold change in
expression, for either metacyclic or amastigote versus pro-
cycliccomparisons(Table2).Formetacyclicversuslogarith-
mic promastigote comparisons, 27/36 (75%) of the regulated
genes identiﬁed in our microarray analysis were conﬁrmed,
showing at least two-fold changes in expression in Northern
blots. For the amastigote versus logarithmic promastigote
comparisons, 21/35 (60%) were conﬁrmed by this criterion.76 N.S. Akopyants et al./Molecular & Biochemical Parasitology 136 (2004) 71–86N.S. Akopyants et al./Molecular & Biochemical Parasitology 136 (2004) 71–86 77
The percent conﬁrmation values compared well with those
obtained by other workers [32,33]. It should also be noted
that the disagreement between the Northern blot and mi-
croarray estimates was often minor, reﬂecting the strict use
of the two-fold cutoff.
Secondly, we considered those comparisons in which
changes in expression of less than two-fold had been pre-
dicted by microarray analysis (i.e., ‘not regulated’). For
metacyclic versus logarithmic promastigote comparisons,
Northern blot analysis conﬁrmed the lack of regulation for
21/36 (58%), while for amastigote versus logarithmic pro-
mastigote comparisons this value was 29/37 (78%; Table 2,
Fig. 2). When extrapolated to the numbers of genes classi-
ﬁed as 0/3 or 1/3 in the Venn analysis, these data suggest that
the microarray experiments failed to identify a signiﬁcant
number of transcripts showing changes in developmental
expression.
A supporting perspective comes from ‘efﬁciency’ tests;
these calculations were based upon genes that were repre-
sented multiple times on each microarray, as independent
shotgun fragments or speciﬁcally designed PCR products.
Whiletheinsertsdifferedsomewhatinsizeand‘coverage’of
target ORFs, this provided a real-world test of the variability
likely to occur for those genes occurring only a single time78 N.S. Akopyants et al./Molecular & Biochemical Parasitology 136 (2004) 71–86
in our microarrays. These data showed that the ‘efﬁciency’
varied widely for a given locus, ranging from 24–76% of
the spots showing two-fold or greater changes in expression.
It is likely that a similar fraction was missed in the global
analysis. A ﬁnal perspective comes from comparisons with
another study employing our shotgun DNA library collec-
tion in expression proﬁling [34]; remarkably, the overlap in
the set of genes identiﬁed there for the procyclic– stationary
phase transition, with those identiﬁed in our study involving
metacyclics, was quite low. This will be addressed in the
discussion.
3.4. Expression patterns and regulated genes identiﬁed
While shotgun DNA library expression proﬁling failed to
identify a large fraction of Northern-blot regulated genes,
those that were identiﬁed by microarray analysis were
subsequently conﬁrmed with good efﬁciency in Northern
blot analysis (68%). In the discussion below we focus on
those genes showing regulation in 2/3 or 3/3 microarray
experiments per developmental transition, or those con-
ﬁrmed by Northern blot analysis. We determined (and
deposited in GenBank) the end-sequences of all of these
for which data were not previously available (except for
13 clones where sequence information was not determined
due to failure in two or more attempts). When possible
we used the then-emerging L. major genome sequence to
identify the likely gene/ORFs associated with each shotgun
Fig. 4. Expression proﬁles. For each gene from the 10,464 random shotgun data set, expression in metacyclics or amastigotes relative to amastigotes
was scored, using a two-fold cut-off and occurrence in at least 2/3 of the experimental comparisons (Table 1, Fig. 2). For the entire genome, nine
potential relative expression proﬁles are possible, and the total number of genes assigned to each proﬁle is shown in each box. The Y-axis corresponds
to expression at least two-fold greater, equal or at least two-fold less than procyclic promastigotes. The X-axis shows the results for comparisons of
promastigotes (to facilitate visualization), metacyclic promastigotes (M) or amastigotes (A).
DNA used on the microarrays. For these DNAs, expres-
sion ratios ranged from 10-fold down (-tubulin, histone
H2B) to 16-fold up (maxicircle transcripts) relative to pro-
cyclics, although most developmental changes were smaller
(Tables 2–4). Since our studies focused on three major
developmental stages, we adopted a simple approach to
clustering and assigned each gene to one of nine possible
expression proﬁle ‘patterns’ (Fig. 4). These classiﬁcations
must be taken cautiously, due to the signiﬁcant problem of
underestimation noted above.
A number of genes showed procyclic, metacyclic or
amastigote-speciﬁc changes in transcript abundance. These
included genes that were previously identiﬁed as stage-
speciﬁc including up regulation of HASP and SHERP in
metacyclics [35], or histones [36,37] and -tubulin [38]
whose transcripts were more abundant in rapidly dividing
procyclic promastigotes, and amastin/tuzin family genes
and homologs with expression elevated in amastigotes [12].
We did not identify any transcripts that were elevated in
metacyclics/decreased in amastigotes, or the reverse.
The two predominant proﬁles were those where meta-
cyclic and amastigote transcripts had the same pattern
relative to procyclics, either both up or down (Fig. 4;
Table 2). This was consistent with the view that meta-
cyclic promastigotes are a pre-adaptive stage, primed for
differentiation into the amastigote stage [5]. These genes
included ones that were jointly elevated (most maxicircle
genes, amastin or tuzin family members, helicase, etc.) orN.S. Akopyants et al./Molecular & Biochemical Parasitology 136 (2004) 71–86 79
Table 3
Summary of genes assigned to expression proﬁles showing stage variation
Probe ID Proﬁle and corresponding gene annotation M/P log2 A/P log2
P, M > A
lm01e04 Tryp speciﬁc (I) −0.96 −1.39
lm04c06 No sequence could be obtained 0.28 −1.08
lm20f10 Tryp speciﬁc (I) −0.77 −1.13
lm34e09 No sequence could be obtained −0.83 −0.93
lm46d01 Multiple hits to single contig, Lm speciﬁc (I) −0.59 −1.10
lm54f04 Between Lm speciﬁc ORF and Seq 2 from patent US 6426193: Compounds and methods for
detection and prevention T. cruzi infection tryp spec (I)
−0.28 −1.68
lm79f02 Cell wall anchor S. pneumoniae TIGR4, liver stage antigen, putative P. falciparum 3D7, cag
pathogenicity island protein H. pylori (I)
−1.46 −1.54
P>M ,A
lm01d04 LMBT1 L. major mRNA for -tubulin (D) −2.92 −2.74
lm01f04 No sequence could be obtained −1.10 −1.18
lm02f03 Between Lm spec ORF and putative hydrolase of the HAD superfamily S. typhimurium LT2
AAL22806.1 (I)
−1.78 −2.00
lm04f07 Between Lm speciﬁc ORFs hexamer predictions (I) −1.07 −1.12
lm05f07 LMBT1 L. major mRNA for -tubulin (D) −1.69 −1.92
lm18c03 L. hoogstraali LSU 24S  ribosomal RNA, L. donovani 28S  ribosomal RNA gene, 28S ribosomal
RNA subunits , ,  (D, I)
−1.26 −1.55
lm18g10 LMBT1 L. major mRNA for -tubulin (D) −2.25 −2.69
lm22h12 Lm speciﬁc hexamer predictions (I) −1.18 −1.12
lm23h12 Tryp speciﬁc tuzin (D) −2.42 −1.95
lm25g12 AF099108 L. major histone H2B variant 1 (D) −3.21 −2.21
lm34d04 Lm speciﬁc P883.16 L. major (I) −0.94 −1.18
lm35b07 L2969.01L. majorRIKEN cDNA similar to TPR domain containing STI2 H. sapiens (I) −1.65 −1.76
lm36b08 LMBT1 L. major -tubulin (D) −3.15 −3.25
lm65c09 Regulatory subunit of the HslVU complex ATP-dependent heat shock protease T. brucei (I) −3.19 −2.53
lm65d09 H. sapiens cDNA FLJ13633 ﬁs, weakly similar to probable ATP-dependent RNA helicase HAS1 (I) −2.95 −2.81
lm65f12 Between Lm speciﬁc ORFs hexamer predictions (I) −2.77 −1.72
lm66c08 Between ORFs: similar to TR:O57580 high molecular mass nuclear antigen/C. fasciculata RNase H (I) −2.77 −2.85
lm66d08 ArfGap-like zinc ﬁnger protein L. major (I) −3.63 −3.15
lm66e08 Possible monocarboxylate transporter protein L. major (I) −3.82 −2.88
lm66f11 AF200948 1 ABC1 transporter L. tropica (D), score improved with (I) −2.36 −1.59
lm68d08 S. cerevisiae ORF YER129w PAK1; DNA pol  suppressing kinase (I) −2.58 −2.65
lm68d09 Between Lm speciﬁc ORFs hexamer predictions (I) −2.37 −1.98
lm78f02 LMBT1 L. major -tubulin (D) −1.14 −1.42
lm85h01 AF099108 L. major histone H2B variant 1 (D) −0.92 −1.20
lm94h11 LIH42HIST L. infantum H4 histone (D) −2.15 −1.25
ln10b12 LMBT1 -Tubulin L. major (D) −2.94 −2.69
A>P ,M
lm03g12 L. major telomere-associated sequence (LTAS) (I) 0.76 0.99
lm10b07 L. major telomere-associated sequence (LTAS) 0.67 2.09
lm12a08 BCOP coatomer beta subunit T. brucei (D) 0.64 1.12
lm14e10 LME344543 L. mexicana INO1 myo-inositol-1-phosphate synthase (D) 0.73 1.35
lm16g12 Contig too small to be informative 0.84 1.02
lm19a06 Contig too small to be informative 0.29 0.88
lm21c08 Lm speciﬁc, missed by hexamer, ﬂanked by T. cruzi hits, telomere of chr 7 (I) 0.83 1.07
lm22a06 AF262215 1 guanine nucleotide-exchange protein GEP2 O. sativa (I) 0.73 1.32
lm22e02 Contig too small to be informative 0.86 1.61
lm22g06 Lm speciﬁc 5  ORF is AL161316 L. major PAC P223 left similar to TR:O35615 friend of GATA-1
(FOG) (I)
1.04 1.12
lm22g09 Tryp speciﬁc, missed by hexamer, weak hit to T. brucei 28H13.160 GTP-binding elongation factor
Tu putative (I)
0.58 1.42
lm22h04 No sequence could be obtained 0.92 1.13
lm24d07 Maxicircle, ND8, ND9, MURF5 0.32 1.24
lm24g05 L. major telomere-associated sequence (LTAS) (D) 0.39 1.36
lm25a04 LMU16999 L. major ribosomal protein (L-11) gene (I) 0.77 1.29
lm27a12 Methionine synthase, vitamin-B12 independent isozyme AAC76832.1 (I) 0.21 1.03
lm30g06 No sequence could be obtained 0.33 1.05
lm30h06 Tryp speciﬁc L1063.05 L. major 25N14.175 Ribosomal RNA processing protein (D) 0.52 1.30
lm32h06 L1063.05 L. major 25N14.175 ribosomal RNA processing protein (D) 0.74 1.50
lm41c06 LME344543 L. mexicana ino1 gene for myo-inositol-1-phosphate synthase (D) 0.59 1.0280 N.S. Akopyants et al./Molecular & Biochemical Parasitology 136 (2004) 71–86
Table 3 (Continued)
Probe ID Proﬁle and corresponding gene annotation M/P log2 A/P log2
lm41g11 L. major telomere-associated sequence (LTAS) (D) 0.45 1.45
lm50b02 Tuzin (tryp speciﬁc) (I) 0.98 1.68
lm53h02 L. major telomere-associated sequence (LTAS) (D) 0.59 1.44
lm54f12 No sequence could be obtained N/A 1.32
lm56g02 Probable DNA polymerase zeta catalytic component L. major (D) 0.75 1.25
lm76e03 Amastin-like/tuzin 0.89 0.67
lm79h08 Maxicircle, MURF5 0.11 1.22
lm80g03 Lm speciﬁc (I) 0.87 1.38
lm87h01 Tryp speciﬁc L3204.02 L. major missed by hexamer (D) 0.49 1.11
lm89h03 Human DNA mismatch repair gene (hPMS2), human ribosomal protein L26 (RPL26) (I) 0.69 1.29
lm89h04 Same as lm89h03 0.76 1.23
lm90h02 Tuzin (I) 0.81 1.29
lm95h05 L. major telomere-associated sequence (LTAS) (D) 0.93 1.93
ln10g08 Maxicircle, MURF5 −0.46 0.92
M>P ,A
lm03d07 Tryp speciﬁc P883.16 L. major (D) 1.31 0.77
lm15a08 L. infantum LORIEN, and S-adenosylmethionine synthetase (metK) (D) 1.07 0.63
lm16c06 LEIFL11A L. major ﬂ1.1 (SHERP gene) (D) 1.24 0.11
lm36c09 LMA237587 L. major HASPA1, HASPB, HASPA2, SHERP1 and SHERP2 genes (D) 1.06 −0.19
lm47g01 Tryp speciﬁc (I) 0.99 0.94
lm54e08 L4768.01 L. major X87839.1 PFRNACRK3 P. falciparum serine/threonine protein kinase (I) 1.06 0.27
lm63f03 AJ237587.1 LMA237587 L. major cDNA16 gene family (HASPA1, HASPB, HASPA2, SHERP1
and SHERP2 genes) (D)
1.60 −0.31
lm66b01 Between 36E18.195 T. brucei variant surface glycoprotein, pseudogene/AF461508 1
farnesyltransferase  subunit L. major (I)
1.38 −0.21
lm66b02 Between AF272035 1 Rag C H. sapiens, AF323609 1 GTPase-interacting protein 2/putative small
GTPase H. sapiens (I)
1.29 −0.14
lm68b02 Between H. sapiens retinol dehydrogenase/G-protein  A. thaliana, S. cerevisiae (I) 1.22 −0.22
lm76d07 AY079097.1 L. major P1/S1 nuclease (D) 1.05 0.52
lm78c08 AF084473 1 pteridine transporter FT5 L. donovani (D) 1.47 0.72
lm86g06 AF195531 1 amastin-like surface protein L. donovani, L. infantum (D) 1.14 −0.18
lm88b10 No sequence could be obtained 1.07 0.89
lm91a12 M31136.1 LEIHSP70R L. major heat shock 70-related protein (D) 1.00 0.19
lm96d02 Tryp speciﬁc (I) 0.98 1.03
lm99d11 Lm speciﬁc (I) 1.59 −0.10
ln02e11 No sequence could be obtained 1.77 −0.15
ln09f07 No sequence could be obtained 0.90 0.17
P ,A>M
lm43h09 L. infantum H4 histone (D) −0.86 −0.99
lm52d05 L. donovani, L. infantum histone H2A, L infantum H2A4, H2A5, H2A6 (D) −1.97 −0.74
lm65h04 F. nucleatum mg1 l-met--deamino--mercaptomethane-lyase, methyltransferase HgiDIM (I) −1.30 −0.47
lm68c09 Lm speciﬁc (I) −2.56 −0.89
lm68e12 Lm speciﬁc (I) −1.58 −1.08
lm76b11 L. infantum H4 histone (I) −1.42 N/A
lm91d09 L. infantum H4 histone (D) −1.41 −0.84
M ,A>P
lm02d01 Maxicircle X02438 L. tarentolae maxicircle DNA fragment (D) 2.00 2.91
lm08a12 Lm speciﬁc 5  ORF AF115507 L. donovani heat shock protein HSP60 (with hits in tryps) (I) 1.66 1.94
lm09f10 Maxicircle, MURF5, ND7 1.25 2.06
lm19e02 L. major telomere-associated sequence LTAS (D) 1.89 2.86
lm19e06 Maxicircle M28690.1 LEIND1PUT L. major NADH dehydrogenase subunit 1 (ND1) (D) 2.38 2.62
lm20b02 Maxicircle, NADH-ubiquinone oxidoreductase chain 5 (ND5) 1.24 1.72
lm22d04 Amastin-like 5  ORF is tuzin tryp speciﬁc (I) 1.06 1.38
lm23g06 Similar to helicase homolog H. sapiens, M. musculus (I) 1.34 1.62
lm24g06 Maxicircle, NADH-ubiquinone oxidoreductase chain 4, 5 (ND4, ND5) 2.02 2.12
lm30g05 Maxicircle, NADH-ubiquinone oxidoreductase chain 5 (ND5) 1.14 1.89
lm31e09 Maxicircle, L. tarentolae kinetoplast mitochondrial cytochrome oxidase (COII) 1.58 1.56
lm45g01 Tuzin, tryp speciﬁc (D) 1.19 1.06
lm46a12 Lm speciﬁc ORF missed by hexamer (I) 1.51 1.77
lm48b10 Maxicircle, Z22728.1 KPLMDIVRB L. mexicana kinetoplast divergent region 1.85 4.38
lm59f09 Maxicircle, MURF1 L. major NADH dehydrogenase subunit 1 (ND1) 1.50 1.61
lm63h12 Maxicircle, M92830.1 LEIDRC L. mexicana cytochrome b 1.01 1.21N.S. Akopyants et al./Molecular & Biochemical Parasitology 136 (2004) 71–86 81
Table 3 (Continued)
Probe ID Proﬁle and corresponding gene annotation M/P log2 A/P log2
lm65h05 I52484 gene PIG-A protein mouse XP 136136.1, GPI-anchor biosynthesis PIG-A XP 204385.1 (D) 0.99 1.85
lm66c12 AL161168 L. major cosmid L6823 t7 similar to TR:Q14886 mucin, possibly tryp speciﬁc (D) 2.03 1.06
lm68g05 Lm speciﬁc missed by hexamer ﬂanking ORF T00243 sopA protein E. coli plasmid pO157 (I) 2.47 2.35
lm77d07 Maxicircle, X01094.1 MITBCOX T. brucei mitochondrial gene for cytochrome c oxidase subunits I
and II (coxI and coxII) (D)
2.25 1.95
lm78d07 DEAD/DEAH box ATP-dependent RNA helicase P. falciparum 3D7 CAD50579.1 (D) 1.93 1.33
lm80d12 Maxicircle, L. tarentolae mitochondrial 12S ribosomal RNA gene 1.68 2.25
lm81c07 AF339905S3 L. major DNA-directed RNA pol III also this clone has LTAS so cannot be assigned
deﬁnitively (I)
1.24 1.33
lm87h02 X94753 C. albicans GFA1 gene for fructose-6-phosphate amidotransferase (D) 1.10 1.94
lm88h01 Cysteine protease L. major (D, I) 1.50 2.72
lm88h02 Between two tryp speciﬁc ORFs probable mitochondrial oxaloacetate transport protein/S. pombe
NP 593169.1 (I)
1.84 3.11
lm88h03 Maxicircle, divergent region 0.93 1.64
lm89h01 No sequence could be obtained 0.92 1.57
lm89h02 Tryp speciﬁc linked to telomere 7 but no LTAS (I) 1.13 2.19
The table shows the properties of genes assigned to the proﬁles shown in Table 4. M/P or A/P shows the log2 of the metacyclic or amastigote to
promastigote ratio. The average was calculated from all three replicates, regardless of their Venn classiﬁcation. Clones showing a signiﬁcant dye-swap
(DS) effect in microarray experiments are not shown. Two kinds of comparisons were noted; in many cases, the available DNA sequence for each clone
showed a strong similarity to a known gene by BLASTN or TBLASTX search (10−20); these are considered ‘direct’ hits (D). When a hit was not obtained,
we identiﬁed the largest assembled portion of the Leishmania genome project matching the sequence and performed database searches using 10kb of
sequence ﬂanking either side; in many cases we could identify a nearby ORF that was likely to be the transcript seen by the probe; these are labeled
‘indirect’ (I). In some cases we were unsure which ﬂanking ORF was identiﬁed, and both are then reported. In addition to publicly available sequence,
we also searched private collections of sequence for T. brucei and T. cruzi to discern “tryp speciﬁc” GSS, i.e., with similarity hits in other trypanosomes,
versus “Lm speciﬁc” GSS, having no similarity to any other available sequence. “No sequence could be obtained” indicates GSS that we were unable
to obtain sequence despite multiple attempts. “Contig too small” indicates a GSS for which we could not identify a sufﬁciently large portion of the
assembled Leishmania genome to perform meaningful similarity searches of the surrounding region. Preliminary sequence data was made available from
the Leishmania and trypanosome genome sequencing centers (Seattle Biomedical Research Institute, The Institute for Genome Research and Sanger).
decreased (-tubulin, histones H2B, H4, etc.) in the two
stages.
While we did not speciﬁcally attempt to study maxicircle
geneexpression,thoseoccurringinourDNAshotgunlibrary
gave good coverage of the majority of known maxicircle
genes. Notably, most transcripts arising from the Leishma-
nia maxicircle were elevated in both amastigotes and meta-
cyclics. Table 4 summarizes the results obtained from both
DNA shotgun microarray expression proﬁling as well as
Northern blot analysis, and comparisons with T. brucei are
shown in Fig. 5. The agreement between both approaches
was good, with a similar 2–4-fold increase in metacyclic and
lesion amastigote expression seen for all genes. Two factors
need to be considered: ﬁrst, while many DNA probes iden-
tiﬁed single maxicircle genes, others spanned two or more
(Table 4). However, the overall trend and the presence in
some cases of overlapping probes identifying different gene
sets suggest that this is not likely to alter the conclusion of
up-regulation. Secondly, the potential effect of RNA editing
must be considered, as our probes were unedited genomic
DNA [39]. Based upon the L. tarentolae sequence, the abil-
ity of transcripts arising from MURF5, ND7, COIII, CytB,
ND1, MURF1, ND3, COII, MURF2, CO1, ND4, and ND5
to hybridize to genomic DNA would be expected to be high
and unaffected by editing, while for the other probes at least
35% of each gene was potentially able to hybridize to the
1kb shotgun DNA probes used in microarrays, or Northern
blots (Table 4). The effect of editing may account for the
Fig. 5. Comparison of maxicircle gene expression in Leishmania ma-
jor and Trypanosoma brucei. This ﬁgure summarizes the results ob-
tained in the Northern blot and microarray studies found in this work
for Leishmania major, and Northern blot results previously reported in
Trypanosoma brucei [54,55]. Missing entries mean that no data are avail-
able. The map is based upon that of L. tarentolae; white boxes depict
genes, within which black regions correspond to extensively edited re-
gions in this species [39]. The abbreviations represent developmental
stages; for Leishmania these correspond to procyclic promastigote (P),
metacyclic promastigote (M) and lesion amastigotes (A), while for try-
panosomes this corresponds to culture procyclic (P) and bloodstream (BS)
forms. Please see the website maintained by L. Simpson for more de-
tails about the trypanosome and Leishmania maxicircle and its transcripts
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Table 4
Relative developmental expression of Leishmania major maxicircle genes
Probe Genes identiﬁed by probea DNA microarrayb Northern blotc Percent probe not affected by editing
lm80d12 12S rRNA 1.7/2.2 (DS) 2.1/2.1 100
lm66g08 9S rRNA −0.5/NA 1.7/1.2 100
lm29f06 9S rRNA −0.2/0.9 No bands 100
lm66g08 ND8 −0.5/NA 1.7/1.2 50
lm29f06 ND8, ND9 −0.2/0.9 No bands 50, 35
lm24d07 ND8, ND9, MURF5 1.0/1.2 ND 50, 35, 100
lm09f10 MURF5, ND7 1.2/2.1 1.3/2.0 100, 88
lm63h12 CytB 1.0/1.2 No bands 100
lm98c05 CytB NA 1.6/2.2 100
lm19e06 MURF1, G3, ND1 1.5/1.6 1.4/1.6 100, 55, 100
lm59f09 MURF1, G3, ND1 2.0/2.6 (DS) 1.6/2.2 100, 55, 100
lm54g04 ND1, COII 2.7/2.7 (DS) 2.0/2.5 100, 99
lm31e09 COII, MURF2 1.6/1.6 1.3/1.0 99, 94
lm77d07 MURF2 2.2/2.0 ND 100
lm15c04 COI 3.8/3.1 (DS) 2.8/2.5 100
ln03e03 COI 2.1/1.7 (DS) 1.1/0.7 100
lm80g05 COI, G4 2.6/1.6 (DS) 1.2/1.3 100, 50
lm44c10 G4, ND4 2.7/3.1 (DS) 1.3/1.5 50, 100
lm24g06 ND4, ND3, RPS12 2.0/2.1 0.7/1.5 100, 45, 30
lm20b02 ND5 1.2/1.7 2.0/1.4 100
lm02c02 ND5 1.6/0.6 (DS) −0.8/1.5 100
lm09e03 ND5 2.4/2.8 (DS) 0.3/0.4 100
lm30g05 ND5 1.1/1.9 ND 100
lm48b10 ND5 1.8/4.4 ND 100
lm02d01 Divergent region 2.0/2.9 ND 100
lm19g09 Divergent region 2.9/4.2 (DS) 1.8/2.6 100
lm88h03 Divergent region 0.9/1.6 ND 100
lm29h06 Divergent region 2.6/4.0 1.1/1.8 100
lm32e03 Divergent region 2.6/4.0(DS) ND 100
a Genes identiﬁed by probe (L. tarentolae gene nomenclature).
b log2 ratios (average of three microarray experiments) for metacyclic/amastigote stages compared to procyclic stage. DS, these spots showed signiﬁcant
differences in ‘dye-swap’ experiments and the microarray result may be unreliable. Italicized numbers mark those showing more than two-fold changes.
c log2 ratios for Northern blot comparisons as in footnote B. ND, not done; NA, not available. Please see the website maintained by L. Simpson for
more details about the L. tarentolae maxicircle and its transcripts (http://dna.kdna.ucla.edu/trypanosome/database.html).
marginal regulation attributed to ND8/ND9 (Table 4) and
the classiﬁcation of these probes as elevated in amastigotes
(lm24d07, lm79h08 and ln10g08; Table 3). Interestingly,
the ND8/ND9/MURF5 probe lm24d07 showed this pattern,
while the adjacent probe lm09f10 containing MURF5 and
ND7 showed elevated expression in both metacyclic and
amastigote stages, which may suggest that MURF5 does un-
dergo coordinate regulation. It is likely that a more compre-
hensive analysis of both edited and unedited transcripts may
clarify the true situation, and reveal additional regulatory
changes.
4. Discussion
Here we undertook a global examination of changes in
mRNA expression in the three major forms that occur within
the infectious cycle of Leishmania, using microarrays based
upon random 1kb shotgun DNA fragments. Three conclu-
sions were drawn: (1) that the fraction of genes whose mR-
NAs show changes in abundance throughout the infectious
cycle seemed to be much lower than seen in other organisms;
(2) that this conclusion was a serious underestimate and that
many differentially regulated genes may have been missed,
and (3) despite the inefﬁciency in their identiﬁcation, a num-
ber of genes showed signiﬁcant changes in stage-speciﬁc
regulation, including a large number of previously unchar-
acterized genes. The role of these genes in parasite develop-
ment is now ripe for further study, and new perspectives on
well-known genes such as those encoded by the maxicircle
were also obtained.
The conclusion that a modest number of transcripts
showed up or down regulation was reached following the
analysis of replica experiments comparing metacyclic or
amastigote versus procyclic mRNA expression, as summa-
rized in Figs. 1 and 2. The data showed that if a criterion
of requiring an expression ratio of at least two-fold in at
least 2/3 replicas was used, only ∼1% of the genes showed
changes in expression. While further analysis suggested that
other (lower) cut-offs might be considered, we applied this
more conservative value in keeping with other studies and
also our own assessment of both experimental and biological
relevancy (discussed more below). Notably, our conclusion
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regulation was not strongly affected by this choice (Fig. 1),
and other methods of statistical analysis yielded similar
results about the DNAs showing developmental changes in
transcript abundance (analysis not shown). Direct analysis
of relative transcript abundance by Northern blot analysis
strongly supported results above, with conﬁrmation of 68%
of the ‘regulated’ calls (Fig. 3; Table 2).
Our studies may be compared to previous studies em-
ploying similar strategies involving random shotgun DNA
libraries in trypanosomatids. In T. brucei comparisons in-
volving a library of 21,024 2kb probes against bloodstream
and procyclic form parasite RNAs revealed that about 2%
showed greater than two-fold differences in expression [18].
Similarly, in T. cruzi comparisons involving a library of 4400
DNAs identiﬁed 60 (1.4%) whose transcript levels varied
during differentiation from trypomastigotes to amastigotes
[40]. Saxena et al. [34] recently reported a study of L. major
employing our shotgun DNA library set, where RNAs were
isolated from promastigotes at various times from growing
to stationary phase (some percentage of which are meta-
cyclics [5]). These workers assessed regulation using a sta-
tistical Z-score based test rather than two-fold cut-off criteria
as our studies or those cited above, which often led to clas-
siﬁcation of genes showing changes in regulation of much
less than two-fold. They also used stationary phase rather
than puriﬁed metacyclic promastigotes, making it difﬁcult to
compare their data with ours. These authors concluded that
15% of the genes showed statistically signiﬁcant changes in
expression at one or more time point in transition, with 1.3%
showing regulation at two or more time points. Remarkably,
and in contrast to our results, the methods used there did
not yield many classic genes showing up or down regulation
in metacyclics in previous studies. Moreover, if one applies
the standard two-fold cut-off criterion to their ﬁndings, the
number of transcripts showing differential expression drops
considerably to a range similar to that found in our study.
Another study using 2000 EST probes encompassing
∼1000 genes of L. major concluded that about 14% of
the genes were signiﬁcantly up-regulated in lesion-derived
amastigotes [41], signiﬁcantly higher than the 0.6–3.1%
found here. As the EST library was not available, we took
an in silico approach and used EST and shotgun library
sequence data to identify 224 DNAs present on our microar-
rays that are also in the EST library. Of these, we found 9
and 10 scored as regulated in at least 2/3 of our amastigote
and metacyclic data sets, respectively (4 and 4.5%), about
3–4 times the level seen in our global analysis. Since the
limited EST collection should be skewed towards the most
abundant RNAs, potentially this is one contributing factor.
As to the remainder, inspection of the data presented by
Almeida et al. [41] suggests that in fact the fraction of
genes showing signiﬁcant regulation may be comparable
to our upper estimates (3.1%), with Almeida et al. assign-
ing signiﬁcance to differences that we do not due to the
incorporation of clustering methodology. Thus, effectively
all four studies using double-stranded DNA probes reached
a similar conclusion about the relative paucity of genes
showing differential expression.
Despite the agreement of the ﬁndings above with prior
studies in trypanosomatids, we challenged our ﬁndings by
performing a large number of Northern blot comparisons.
As noted earlier, about 68% of the genes showing differ-
ential expression in shotgun microarray comparisons were
conﬁrmed by Northern blots. However, our analysis of genes
assignedtothe1/3and0/3Vennmicroarrayclasses,andthus
considered to be ‘unregulated’ by these criterion, revealed
that 32% of these showed greater than two-fold changes in
expression by Northern blot analysis (Fig. 2, Table 1). Since
the 0/3 and 1/3 Venn microarray classes represent the vast
majority of genes, these and other ﬁndings suggest that in
fact DNA shotgun library expression proﬁling greatly un-
derestimates the true fraction of transcripts showing signiﬁ-
cant changes in expression. Perhaps more tellingly, the set of
genes identiﬁed in our study showed little overlap with those
identiﬁed in the procyclic-stationary phase transition in a
prior study using our Leishmania shotgun DNA library [34].
As in our study, Northern blot analysis conﬁrmed differen-
tial regulation of most genes identiﬁed by microarray. Thus,
the discrepancies seem to revolve around genes whose dif-
ferential expression was missed, by either microarray study.
Collectively, these studies argue that the use of shotgun
DNA microarrays in these parasites provides at best an
imperfect perspective on changes in transcript abundance.
Why should this be the case in Leishmania, in contrast
to their success in other organisms? One factor may be
that the Leishmania genome, while lacking in interspersed
repetitive DNA elements, nonetheless contains a variety of
simple sequence repeats ranging upwards from the com-
mon dinucleotide repeats (CA:GT, CT:GA); these are most
prevalent in ‘inter-transcript’ regions but also occur within
mRNAs [42]. Secondly, for a number of genes antisense
transcription and transcripts have been identiﬁed, which
could show differential expression during development
[43–46]. Both of these factors would lead to underestimates
in assessing changes in relative expression in microarray
analysis by effectively increasing ‘background’ hybridiza-
tion, and for genes undergoing only modest changes, would
lead to their being missed entirely. These notions lead to
the prediction that both of these factors would be mitigated
if strand-speciﬁc,‘coding-region’ speciﬁc probes were used
for microarrays, and some evidence supporting these ideas
may be evident in the EST comparisons discussed above
[41]. Recently, microarrays using long oligonucleotides
with these properties have been developed, and we are cur-
rently testing whether these show improved performance
by the criteria established above.
Previous surveys seeking to identify stage-regulated tran-
scripts in Leishmania have revealed remarkably few [8–12].
However, in general the methods used preferentially yield
genes whose transcript abundances differ greatly, to the
exclusion in some cases of those showing more modest
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studies completed thus far the fold regulation values are typ-
ically modest (seldom more than 2–10 folds). This suggests
the interesting possibility that regulation in Leishmania
primarily involves smaller changes in mRNA abundance,
since as parasites these organisms can rely upon their sand
ﬂy or mammalian hosts to provide relatively constant and
predictable environments. Similar ﬁndings have emerged
from studies of a number of viral pathogens, which can
exert relatively modest global effects on host mRNA syn-
thesis despite radically affecting overall host metabolism
[47,48]. Moreover, the importance of post-transcript regula-
tory mechanisms have been emphasized extensively in both
Leishmania and trypanosomes (reviewed in [7,46,49]). No-
tably, adaptations of expression proﬁling technology have
been developed to probe changes in RNA turnover, synthe-
sis and translation. Our ﬁndings also emphasize the value
of studies focusing on the Leishmania proteome, several of
which are underway.
4.1. DNA microarrays as a tool for gene discovery
One goal of this study was to identify genes showing reg-
ulation in transcript abundance during the parasite infectious
cycle, and in this regard we have identiﬁed at least two hun-
dred. These included known genes whose role in parasite
biology and virulence are understood or under investigation,
summarized in Tables 2 and 3. A number of genes showing
relationship to proteins of known function were identi-
ﬁed, but whose transcript abundance had not been studied
previously. One example involves inositol metabolism, as
inositol-1-phosphate synthase transcripts were elevated in
amastigotes and metacyclics (Tables 2 and 3). The Leish-
mania surface is heavily populated by inositol-containing
molecules including glycosylphosphatidylinositol (GPI) an-
chors and inositol phosphoceramides [50,51]. GPI-anchored
molecules have been implicated in parasite virulence,
and inositol is essential for viability [51]. Interestingly,
ﬁve DNAs containing Leishmania telomeric repeat se-
quences [52] showed up-regulation in both metacyclic and
amastigote cells, suggesting the possibility of changes in
telomere-associated gene expression, as seen previously in
T. brucei antigenic variation (reviewed by [53]).
One interesting story involved transcripts from the Leish-
mania maxicircle, which is part of the kinetoplast DNA
network and is related to the mitochondrial DNA of other
organisms [39,54].I nT. brucei, some transcripts show
up-regulation in the mammalian bloodstream infecting
stages, while others are suppressed (Fig. 5; [54,55]). In
contrast, in Leishmania it appears that all maxicircle tran-
scripts are up-regulated in both metacyclic and amastigote
stages (Table 4, Fig. 5). Our analysis suggests that this
ﬁnding does not arise from the effects of RNA editing,
based upon sequence analysis of the maxicircle DNAs and
edited transcripts of L. tarentolae.( Table 4). Differences in
maxicircle transcript abundance may relate to differences in
energy metabolism between the bloodstream trypanosomes
and the intra-phagosomal Leishmaniaamastigotes [56], with
a heightened demand occurring in the infective Leishmania
stages. It is interesting that no nuclearly-encoded genes
involved directly in oxidative phosphorylation showed dif-
ferential regulation (Table 3), however these may have been
missed for technical reasons discussed earlier.
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